AETHLON MEDICAL, INC. Proceeds from Fees Received
AETHLON MEDICAL, INC. (AEMD) reported Proceeds from Fees Received of $3.30 million for the 12-month period ending 2026-03-31, per its 10-K filed 2026-06-10.
Financial Statements › Cash Flow › Financing Activities
us-gaap:ProceedsFromFeesReceived · last filed 2026-06-10
- AETHLON MEDICAL, INC. proceeds from fees received for the quarter ending 2026-03-31 was $0.00.
- AETHLON MEDICAL, INC. proceeds from fees received for fiscal 2026 was $3.30M.
| Period end | Proceeds from Fees Received 0 month | Proceeds from Fees Received 3 month | Proceeds from Fees Received 9 month | Proceeds from Fees Received 12 month |
|---|---|---|---|---|
| 2026-03-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-06-10 | $3.30M 10-K · filed 2026-06-10 | ||
| 2025-12-31 | $3.30M 10-Q · filed 2026-02-12 | |||
| 2025-09-05 | $4.50M 10-Q · filed 2025-11-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Bluejay Diagnostics, Inc. (BJDX) | United States | $0.004B | |
| INTELLIGENT BIO SOLUTIONS INC. (INBS) | United States | $0.005B | |
| OSR Health, Inc. (OSRH) | United States | $0.004B | -0.75 |
| Adagio Medical Holdings, Inc. (ADGM) | United States | $0.004B | |
| Autonomix Medical, Inc. (AMIX) | United States | $0.004B | |
| Sonoma Pharmaceuticals, Inc. (SNOA) | United States | $0.006B | -2.59 |
| enVVeno Medical Corp (NVNO) | United States | $0.006B | -0.48 |
| Beyond Air, Inc. (XAIR) | United States | $0.003B | -0.01 |
| Vivos Therapeutics, Inc. (VVOS) | United States | $0.003B | -0.26 |
| Co-Diagnostics, Inc. (CODX) | United States | $0.007B | -0.32 |